Institut Paoli-Calmettes Clinical Trials
Sponsors / Institut Paoli-Calmettes
Institut Paoli-Calmettes appears as lead sponsor on 148 trial records in ClinicalTrials.gov. The portfolio currently includes 32 recruiting studies, 6 active non-recruiting studies, and 55 completed studies. 9 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, business or strategic decisions. Cumulative planned enrollment across all listed trials is 254,217 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
148
Total Trials
32
Recruiting
6
Other Active
55
Completed
9
Terminated / Withdrawn
254,217
Total Enrollment
Termination reasons: Recruitment44% · Other33% · Business22%
Recent Terminations
- Breast Cancer"Sponsor decision"
- NCT01521676 Stopped Jan 2026Breast Cancer"strategical decision"
- Advanced or Metastatic Melanoma"lack of recruitment"
- NCT01980277 Stopped Dec 2018Breast Cancer"Drug development stopped"
- Non Castrate Metastatic Prostate Cancer"Defect of recruitment"
- NCT01589861 Stopped Oct 2017Breast Cancer"Drug development withdrawn"
- NCT02525211 Stopped Oct 2017Breast Cancer"Recruitment defect"
- Cancer"Insufficient recruitment"
- Androgen-independent Prostate Cancer"Insufficient biological material for analysis"
Active Trials (6 total)
- Acute Myeloid Leukemia PHASE2NCT06055621
- Acute Myeloid Leukemia PHASE2NCT06557421
- NCT05529862
- Inflammatory Breast Cancer PHASE2NCT03515798
- Acute Myeloid Leukemia PHASE2NCT01985061
- Acute Myeloid Leukemia PHASE2NCT03597321
- NCT04185272
- NCT04504747
- NCT06046794
- NCT04520932
- NCT06894082
- NCT06072027
- NCT03595787
- NCT03977779
- NCT05955196
- NCT04655885
- NCT04677244
- NCT01717131
- NCT03961776
- NCT01977274